Join to View Full Profile
11333 Sepulveda BlvdMission Hills, CA 91345
Phone+1 818-365-9531
Fax+1 818-792-4793
Dr. Kedia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Rohit Kedia is a board certified in internal medicine/endocrinology and obesity medicine and work in a large multi-specialty medical group in southern California. He sees a wide variety of endocrine cases and does thyroid nodule biopsies. In addition, he is an investigator for national clinical trials.
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
Wright State UniversityResidency, Internal Medicine, 2011 - 2014
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2011
Certifications & Licensure
CA State License 2014 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Mylan Insulin Glargine Study Start of enrollment: 2017 Nov 29
- A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men Start of enrollment: 2018 May 03
- Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity Start of enrollment: 2018 Jun 04
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsA retrospective review of insulin requirements in patients using U-500 insulin hospitalized to a Veterans Affairs Hospital.Rohit Kedia, Cyrus V. Desouza, Lynette M. Smith, Vijay Shivaswamy
Journal of Diabetes and Its Complications. 2017-05-01 - 2 citationsNuclear Imaging in Metastatic Paraganglioma.Rohit Kedia, Neil J. Hansen, Whitney S. Goldner
Journal of Nuclear Medicine Technology. 2016-12-01 - 6 citationsSpotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic reviewRohit Kedia, Supriya Kulkarni, Meredith Ross, Vijay Shivaswamy
Patient Preference and Adherence. 2016-09-30
Press Mentions
US Obesity Docs Expect Lilly Weight-Loss Drug to Show Similar Heart Benefit as WegovyDecember 2nd, 2023- US Obesity Doctors Expect Weight-Loss Drug Lilly to Have Similar Cardiac Benefit to WegovyDecember 4th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
